Yervoy

Bristol-Myers Skin-Cancer Drug Yervoy Rejected by U.K. Health Cost Agency
Bristol-Myers Skin-Cancer Drug Yervoy Rejected by U.K. Health Cost Agency
Bloomberg
UK
Yervoy
Bristol-Myers Squibb
NICE
skin cancer
Flag link:
Yervoy may face Roche rival sooner than expected
Yervoy may face Roche rival sooner than expected
Fierce Pharma
Bristol-Myers Squibb
Zelboraf
melanoma
Yervoy
Roche
Flag link:
Yervoy hits the market with $95M bang
Yervoy hits the market with $95M bang
Fierce Pharma
Yervoy
Bristol-Myers Squibb
melanoma
Flag link:
As Dapagliflozin Receives Negative Vote, What's Next for Bristol Myers?
As Dapagliflozin Receives Negative Vote, What's Next for Bristol Myers?
Seeking Alpha
Bristol-Myers Squibb
Dapagliflozin
Pfizer
Eli Lilly
AstraZeneca
JNJ
Yervoy
Flag link:
Second Phase 3 Study of YERVOY™ (ipilimumab) in Metastatic Melanoma Meets Primary Endpoint of Overall Survival
Second Phase 3 Study of YERVOY™ (ipilimumab) in Metastatic Melanoma Meets Primary Endpoint of Overall Survival
Yahoo/BusinessWire
Yervoy
Bristol-Myers Squibb
melanoma
Flag link:
Roche, Bristol Melanoma Drugs Shine
Roche, Bristol Melanoma Drugs Shine
The Street
Roche
Bristol-Myers Squibb
melanoma
vemurafenib
Yervoy
Flag link:
Bristol-Myers, Roche team up on melanoma drugs
Bristol-Myers, Roche team up on melanoma drugs
Yahoo/AP
Roche
Bristol-Myers Squibb
melanoma
Yervoy
vermurafenib
Flag link:
Melanoma Set to Be a Hot Topic at ASCO
Melanoma Set to Be a Hot Topic at ASCO
WSJ Online
ASCO
melanoma
skin cancer
Yervoy
Bristol-Myers Squibb
Daiichi Sankyo
Roche
Flag link:
Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Coming
Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Coming
Bloomberg
Roche
skin cancer
melanoma
vemurafenib
GSK
Bristol-Myers Squibb
Daiichi Sankyo
Yervoy
Flag link:
The Big Winner of the EU Drug Approval Bonanza
The Big Winner of the EU Drug Approval Bonanza
Motley Fool
Benlysta
Human Genome Sciences
Vibativ
Theravance
GSK
Victrelis
Merck
Xgeva
Amgen
Yervoy
Bristol-Myers Squibb
Fampyra
Acorda Therapeutics
Biogen Idec
Flag link:
Bristol-Myers' Yervoy and Dendreon's Provenge: Similarities Between First Two Active Immunotherapies in Cancer
Bristol-Myers' Yervoy and Dendreon's Provenge: Similarities Between First Two Active Immunotherapies in Cancer
Minyanville
Yervoy
Provenge
Dendreon
Bristol-Myers Squibb
melanoma
prostate cancer
Flag link:
Bristol-Myers Squibb: Ipilimumab Approval Brings Positive Surprises
Bristol-Myers Squibb: Ipilimumab Approval Brings Positive Surprises
Seeking Alpha
ipilimumab
Bristol-Myers Squibb
Yervoy
Flag link:
Is Approval of Bristol-Myers Squibb's Yervoy Start of New Chapter at FDA?
Is Approval of Bristol-Myers Squibb's Yervoy Start of New Chapter at FDA?
Minyanville
FDA
Bristol-Myers Squibb
Yervoy
ipilimumab
melanoma
Flag link:
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Seeking Alpha
ipilimumab
monoclonal antibodies
immunotherapy
Yervoy
Bristol-Myers Squibb
melanoma
Flag link:
[video] The Next Big Thing In Biotech: Bristol-Myers
[video] The Next Big Thing In Biotech: Bristol-Myers
TheStreet.com
Bristol-Myers Squibb
skin cancer
Yervoy
ipilimumab
Flag link:
Biotech Calendar: FDA Drug Approvals in 2011
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Flag link:

Pages